An apparent epidemic of fatal asthma has occurred despite ever-increasing expenditures for asthma medications. Atopy is the genetic predisposition toward responses that result in the formation of large quantities of allergen-specific IgE. Biotechnology has made it possible to manufacture proteins that regulate immune responses.